DiCE Molecules employs 81 employees. The DiCE Molecules management team includes Jeffrey Enejosa (Vice President, Clinical Development), Kevin Judice (Senior Vice President, Lilly Research Laboratories, and CEO of DICE Therapeutics), and Mike Schwaebe (Vice President, Process Chemistry, DICE Therapeutics).
Get Contact Info for All DepartmentsLooking for a particular DiCE Molecules employee's phone or email?